Where Does Abeona Therapeutics Inc (ABEO) Stock Fall in the Biotechnology Field After It Is Down -12.76% This Week?

Abeona Therapeutics Inc (ABEO) is around the top of the Biotechnology industry according to InvestorsObserver. ABEO received an overall rating of 59, which means that it scores higher than 59 percent of all stocks. Abeona Therapeutics Inc also achieved a score of 82 in the Biotechnology industry, putting it above 82 percent of Biotechnology stocks. Biotechnology is ranked 69 out of the 148 industries.

ABEO has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on ABEO!

See Full ABEO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 59 means the stock is more attractive than 59 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Abeona Therapeutics Inc Stock Today?

Abeona Therapeutics Inc (ABEO) stock is lower by -5.09% while the S&P 500 has gained 0.3% as of 1:35 PM on Monday, Sep 18. ABEO is lower by -$0.21 from the previous closing price of $4.03 on volume of 111,571 shares. Over the past year the S&P 500 is higher by 14.45% while ABEO is lower by -0.78%. ABEO lost -$3.02 per share the over the last 12 months. Click Here to get the full Stock Report for Abeona Therapeutics Inc stock.